Search Results
Dr. Matulonis on the Current Treatment Landscape in Ovarian Cancer
Dr. Matulonis Discusses Maintenance in Ovarian Cancer
Dr. Matulonis on CPS as a Potential Biomarker in Advanced Recurrent Ovarian Cancer
Dr. Matulonis on Toxicities With PARP Inhibitors in Ovarian Cancer
Stanford Cancer Institute Breakthroughs in Cancer: Ursula Matulonis, MD
Copy of Dr. Matulonis on the Use of Immunotherapy in Recurrent Ovarian Cancer
Precision Medicine for Ovarian Cancer (2021)
Dr. Ursula A. Matulonis -- ASCO 2014 | Dana-Farber Cancer Institute
The Changing Landscape in Advanced Ovarian Cancer
Dr. Matulonis Discusses Rationale of QUADRA Trial
Looking forward to ASCO: updates in ovarian cancer
Current treatment standards for primary ovarian cancer
